OPEX: Development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies

Author:

Fraenkel Liana,Wei Zhenglin,Ramsey Christine,Wiedmeyer Carole,Michaud Kaleb,Neogi Tuhina,Nowell W. BenjaminORCID,Venkatachalam Shilpa,Broniatowski David A.ORCID

Abstract

Objectives A measure that encompasses both benefits and harms at the individual patient level may facilitate comparisons between treatment options and improve shared decision-making. The objective of this study was to develop a patient reported measure to capture overall experience (including both benefits and harms) of treatment using rheumatoid arthritis (RA) as a case example. Methods Hierarchies for treatment benefits are known. Therefore, we developed a hierarchy of adverse events (AEs) using a series of trajectory mapping and paired comparison surveys. We subsequently used these data to construct a paired comparison survey, asking patients to compare options including both a specified level of benefit and an AE. These data were used to generate a hierarchy of overall experience on treatment. Results 782 participants completed a series of three surveys. The trajectory mapping procedure and a paired comparison survey led to the generation of a hierarchy of AEs with nine levels ranging from No AEs to irreversible serious complications. In a third survey, in which AEs were paired with benefits, participants’ ratings generated a 6-level hierarchy of overall experiences ranging from Major improvement + No, mild or manageable AEs (Level 1) to No improvement + Irreversible AEs (Level 6). Conclusions Using a trajectory mapping approach, we developed a patient reported measure representing the distribution of patients’ overall experiences on treatment. The intent of this measure is to enable patients and their physicians to compare the percentage of patients experiencing each level of outcome, from most to least desirable, across treatments.

Funder

Rheumatology Research Foundation

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference11 articles.

1. The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation;DE Singer;Ann Intern Med,2009

2. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis;A Goldhirsch;J Clin Oncol,1989

3. Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR);SR Evans;Clin Infect Dis,2015

4. Conjoint Analysis Modelling of Stated Preferences: A Review of Theory, Methods, Recent Developments and External Validity;JJ Louviere;J Transp Econ Policy,1988

5. Trajectory mapping: a new nonmetric scaling technique;W Richards;Perception,1995

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3